Top Buy
| Wertpapier | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Insmed Inc. | 30 | 1 | 12 | 1 | 59,50 € | 63,62 € | 6,93 % |
| Merck & Co. Inc. | 30 | 1 | 3 | 0 | 119,20 € | 125,02 € | 4,88 % |
| Neurocrine Bioscience | 32 | 0 | 3 | 0 | 126,15 € | 140,87 € | 11,67 % |
| Cytokinetics Inc. | 33 | 1 | 7 | 0 | 48,60 € | 83,56 € | 71,94 % |
| Intuitive Surgical Inc | 34 | 0 | 0 | 0 | 405,95 € | 394,95 € | -2,71 % |
| Johnson & Johnson | 34 | 1 | 3 | 0 | 135,52 € | 187,15 € | 38,10 % |
| Alnylam Pharmace. | 36 | 0 | 0 | 0 | 143,50 € | 236,30 € | 64,67 % |
| UnitedHealth Group Inc. | 36 | 1 | 6 | 0 | 451,05 € | 543,04 € | 20,39 % |
| Regeneron Pharmaceuticals Inc. | 39 | 1 | 3 | 0 | 976,00 € | 1.006,8 € | 3,16 % |
| Boston Scientific | 49 | 0 | 3 | 0 | 71,00 € | 73,64 € | 3,72 % |
| Vertex Pharmaceuticals Inc. | 49 | 2 | 5 | 0 | 437,65 € | 428,60 € | -2,07 % |
| Biogen Inc. | 50 | 1 | 4 | 0 | 210,70 € | 293,22 € | 39,17 % |
| Eli Lilly Corp. | 54 | 0 | 6 | 0 | 827,80 € | 800,00 € | -3,36 % |